This provider's $19.4M in total Medicare payments ranks in the 95th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 162% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 183% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $368.19 | $144.30 | 2.55x | $223.89 | $345.0K | 2.2K | 692 |
| 2017 | $219.20 | $68.84 | 3.18x | $150.36 | $713.7K | 4.1K | 2.0K |
| 2018 | $337.45 | $152.94 | 2.21x | $184.51 | $1.3M | 8.4K | 4.7K |
| 2019 | $338.25 | $163.30 | 2.07x | $174.95 | $1.2M | 7.5K | 3.1K |
| 2020 | $164.57 | $89.34 | 1.84x | $75.23 | $3.5M | 31.5K | 13.5K |
| 2021 | $178.13 | $114.44 | 1.56x | $63.69 | $5.2M | 64.0K | 20.0K |
| 2022 | $41.88 | $33.02 | 1.27x | $8.86 | $6.2M | 128.7K | 67.0K |
| 2023 | $44.55 | $34.63 | 1.29x | $9.92 | $903.5K | 20.3K | 10.1K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test def 22+ classes | 29.9K | $7.2M | $242.05 | 1.74x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 59.6K | $4.8M | $80.50 | 1.40x |
| G0482 | Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an | 9.5K | $1.9M | $197.08 | 1.58x |
| 80307 | Testing for presence of drug | 25.7K | $1.6M | $64.14 | 2.01x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 45.0K | $1.1M | $24.82 | 1.17x |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 35.7K | $420.3K | $11.76 | 1.02x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 17.0K | $392.4K | $23.14 | 1.25x |
| 87633 | Detection test for multiple types of respiratory virus | 643 | $266.8K | $414.86 | 1.72x |
| 87631 | Detection test for multiple types of respiratory virus | 1.8K | $251.8K | $142.00 | 3.07x |
| 81408 | Molecular pathology procedure level 9 | 82 | $164.0K | $2.0K | 1.50x |
| 87798 | Detection test for organism | 4.3K | $150.8K | $34.85 | 1.64x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 729 | $112.3K | $154.04 | 1.72x |
| 87581 | Detection test for mycoplasma pneumoniae (bacteria) | 2.6K | $90.1K | $34.91 | 1.62x |
| 87640 | Detection test for staphylococcus aureus (bacteria) | 2.6K | $89.5K | $34.76 | 1.52x |
| 87541 | Detection test for legionella pneumophila (water borne bacteria) | 2.5K | $88.9K | $34.90 | 1.62x |
| 87486 | Detection test for chlamydia pneumoniae | 1.9K | $67.1K | $35.01 | 1.74x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 852 | $66.2K | $77.66 | 2.55x |
| 87481 | Detection test for candida species (yeast) | 1.6K | $56.8K | $34.71 | 1.41x |
| 81407 | Molecular pathology procedure level 8 | 54 | $45.7K | $846.27 | 1.42x |
| 87653 | Detection test for strep (streptococcus, group b) | 1.3K | $45.5K | $34.59 | 1.30x |
This provider submits charges 1.61 times higher than what Medicare actually pays.
A markup ratio of 1.61x means for every $100 Medicare pays, this provider initially charges $161. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in PA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Norristown, PA | $340.6M | ✓ Clear |
| Quest Diagnostics Of Pennsylvania, Inc. | Pittsburgh, PA | $130.4M | ⚠️ Flagged |
| Health Network Laboratories, Llc | Allentown, PA | $125.3M | ⚠️ Flagged |
| Sma Medical, Inc. | Feasterville, PA | $100.9M | ✓ Clear |
| Interpace Diagnostics Corporation | Pittsburgh, PA | $95.6M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data